Search

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Thursday, February 29, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Yael David Awarded 2024 Alfred P. Sloan Research Fellowship Yael David Yael David, PhD ,  chemical biologist leading  The Yael David Lab  and   Associate Member of the  Chemical

MSK researchers are making important inroads in understanding and treating pancreatic cancer.

… Saturday, January 1, 2022 For Barbara Brigham, being diagnosed with pancreatic cancer in the fall of 2020 was a devastating blow in an already rough year. She had just lost her mother and husband after long illnesses, both needing extensive care. The 74-year-old semiretired librarian from Long Island

Targeting this signal with drugs might be one way to stop cancers from spreading.

… Thursday, July 26, 2018 Summary Scientists from the Sloan Kettering Institute have identified a key step in the process of metastasis, how cancer spreads to other parts of the body. The step is shared across tumor types and suggests a new angle for targeted therapy. In 90% of cancer deaths, what kills

MSK physicians and researchers design and conduct clinical trials that include adolescent and young adult (AYA) cancer patients, ensuring they are not lost between the typical siloes of adult and pediatric cancer trials.

… Monday, September 13, 2021 MSK physicians and researchers design and conduct clinical trials that include adolescent and young adult (AYA) cancer patients, ensuring they are not lost between the typical siloes of adult and pediatric cancer trials. As a result, more AYA patients benefit from an increasing

A commentary by members of Memorial Sloan Kettering Cancer Center’s (MSK) Bobst International Center along with members of the Bloomberg New Economy International Cancer Coalition (the “Coalition”) calls for global collaboration to reimagine patient-centric cancer clinical trials. The piece was published in the April 19, 2022, “The Future of Cancer Research” special Focus edition of the journal Nature Medicine.

… Thursday, April 21, 2022 A commentary by members of Memorial Sloan Kettering Cancer Center’s (MSK) Bobst International Center along with members of the Bloomberg New Economy International Cancer Coalition (the “Coalition”) calls for global collaboration to reimagine patient-centric cancer clinical trials

After graduate student Irene Dimatulac was diagnosed with osteosarcoma in her knee, treatment at MSK — and support from MSK’s Adolescent and Young Adult Program — allowed her to get back to her life.

… Thursday, July 29, 2021 It was Valentine’s Day in 2020 when Irene Dimatulac learned she had bone cancer in her left knee. “I’d been having pain for a few years, but it finally got to the point of not being manageable,” says the avid rock climber and speech pathology graduate student, who was 25 years

Después de que a la estudiante de posgrado Irene Dimatulac le diagnosticaran osteosarcoma en la rodilla, el tratamiento en MSK —y el apoyo del Programa para Adolescentes y Adultos Jóvenes de MSK— le permitieron volver a su vida.

… Thursday, July 29, 2021 Irene Dimatulac se enteró de que tenía cáncer de hueso en la rodilla izquierda el Día de San Valentín de 2020. “Había tenido dolor durante unos años, pero finalmente llegó al punto de que sentía que no lo podía manejar”, dice la escaladora entusiasta y estudiante de posgrado en

Scott Callahan is the second Gerstner Sloan Kettering student to receive the Joanna M. Nicolay Melanoma Foundation grant, which supports exceptional melanoma research by graduate students.

… Monday, April 28, 2014 Scott Callahan, a second-year student studying in the laboratories of Lorenz Studer in the Developmental Biology Program and Richard M. White in the Cancer Biology and Genetics Program , was awarded a $10,000 melanoma research grant by the Joanna M. Nicolay Melanoma Foundation

Memorial Sloan Kettering Cancer Center researchers have published new findings that may help explain why brain tumors called glioblastomas are so resistant to treatment.

… Friday, April 1, 2011 Summary Memorial Sloan Kettering Cancer Center researchers have published new findings that may help explain why brain tumors called glioblastomas are so resistant to treatment. Memorial Sloan Kettering Cancer Center researchers have published new findings that may help explain

A powerful form of MRI could show whether prostate cancer is likely to grow or spread.

… Thursday, September 26, 2019 Summary An imaging method called hyperpolarized MRI can produce highly detailed pictures of a tumor’s metabolic activity. A new study demonstrates that this approach can give clues about whether a prostate cancer is likely to spread, which could guide treatment decisions.